Struggling to identify local prospects? Our AI BDR Ava taps into a database of 200M+ local Google businesses and does fully autonomous outreach—so you can focus on closing deals, not chasing leads.

Ava operates within the Artisan platform, which consolidates every tool you need for outbound:

Book a demo and supercharge your sales team

💰Cohere is seeking to raise $500 million in new funding at a $5 billion valuation, attempting to close the massive funding gap with OpenAI's $11 billion war chest and Anthropic's $7.3 billion. The enterprise-focused AI company has carved out a niche by targeting business customers with privacy-conscious solutions, contrasting with OpenAI's consumer-first approach through ChatGPT. This fundraising push underscores how capital has become the defining competitive advantage in AI, determining which companies can afford the enormous computational resources needed to train cutting-edge models. Whether Cohere's specialized enterprise strategy can compete against the deep pockets of generalist AI leaders remains an open question in an industry where funding increasingly determines survival.

🤖 Meta's push toward fully automated advertising by 2026 would let businesses create entire campaigns by simply providing a URL and budget, with AI handling all creative development and targeting decisions. Mark Zuckerberg envisions a system where advertisers don't need to get creative, and don't need any targeting demographic – just connect a bank account and let Meta's AI generate imagery, video, text, and determine optimal audiences. While this could democratize advertising for small businesses lacking marketing expertise, it raises questions about whether AI can truly capture brand voice and whether the creative industry will shift from execution to strategy. The move represents Meta's bet that reducing friction for advertisers through total automation will drive platform adoption, even if it means sacrificing some creative control that has traditionally defined effective brand marketing.

💼 Wedbush Securities is launching an AI-focused ETF based on star analyst Dan Ives' research, marking a new trend of Wall Street firms packaging their research insights into investable products. The fund, trading as "IVES" starting June 5, will track 30 companies from Ives' research list including giants like Nvidia and Microsoft alongside smaller players like SoundHound AI, with quarterly rebalancing and a 0.75% fee. While AI-themed ETFs face challenges with many key players remaining private and existing funds barely outperforming individual stocks like Nvidia, Wedbush is betting that AI's expansion "from semis to software, to infrastructure, to consumer" creates new investment opportunities beyond the crowded semiconductor space.

📄 Google Drive's new "Catch me up" feature uses Gemini AI to automatically summarize document changes since your last view, eliminating the tedious task of manually scanning through collaborative files. The feature generates bullet-point summaries of edits in Google Docs and new comments across Docs, Sheets, and Slides, with a visual Gemini circle indicating which files need attention. Rolling out to Workspace Business and Enterprise tiers plus premium subscribers, this update transforms document management from a time-consuming review process into a quick AI-powered briefing. As productivity tools increasingly compete on AI capabilities, Google's focus on solving real workflow pain points—like staying current on team document changes—demonstrates how AI is shifting from novelty to necessity in everyday work.

💊 Artificial intelligence has reached a milestone in drug development as Insilico Medicine's AI-designed treatment for deadly lung fibrosis showed improved patient lung function in mid-stage trials, marking the first success of an AI-created drug targeting an AI-identified biological pathway. The company compressed typical drug development from 4.5 years to just 18 months, with CEO Alex Zhavoronkov calling it "one of the best results people have ever seen" for idiopathic pulmonary fibrosis. However, the study's limitations—only 71 Chinese patients over 12 weeks, with some experiencing liver injuries—temper the enthusiasm, and approval remains at least two years away. While this breakthrough validates billions invested in AI drug discovery, it also highlights the delicate balance between accelerating development timelines and ensuring patient safety in the race to revolutionize pharmaceutical innovation.

💵 Private credit's adaptability makes it uniquely positioned to capitalize on AI's rapid evolution, offering the flexible financing that traditional lenders struggle to provide for unpredictable growth trajectories. Apollo's John Zito highlights how private credit can structure 15- to 20-year loans with flexible terms for hyperscalers, grid providers, and power companies—critical infrastructure that "doesn't get talked about enough." This represents a strategic shift where financial innovation meets technological advancement, as private credit firms develop specialized expertise in funding the data centers and power systems underpinning AI's expansion. While traditional banks hesitate due to AI's unpredictability, private credit's willingness to adapt financing terms could make it the preferred funding source for the infrastructure backbone of the AI revolution.

🏛️ The Trump administration is repositioning the U.S. approach to AI governance by transforming the AI Safety Institute into the Center for AI Standards and Innovation (CAISI), shifting focus from regulatory frameworks to voluntary industry collaboration. Commerce Secretary Howard Lutnick criticized previous approaches as using "censorship and regulations under the guise of national security," signaling a dramatic policy reversal that prioritizes innovation and U.S. dominance in international AI standards. CAISI will focus on "demonstrable risks" like cybersecurity and biosecurity threats rather than broader societal concerns, relying on voluntary agreements with companies instead of mandatory compliance. This transformation illustrates how political philosophies can fundamentally reshape technology governance, raising questions about whether voluntary standards can adequately address AI risks while the U.S. races to maintain its competitive edge against international rivals.